Technology, Innovation & Outdoor News

This timber retreat is small on home comforts but big on simple rustic charm. Intended as a short-stay vacation home, it features a minimalist but comfortable interior that includes a netted hangout area.

While many tiny homes have been trending steadily larger, this off-grid model takes things in the opposite direction. Created with mobility in mind, it would be a good fit for those wanting a nomadic lifestyle.

Nissan has set a new economy record, driving a Qashqai e-Power 1,230 miles across Colombia on one tank. Its special hybrid system uses a gasoline engine only to charge the batteries, offering EV-style driving without ever plugging in.

For years, Hymer has been selling what stands as arguably the most innovative camper van in all the world. This year, its highly self-sufficient Crossover series draws closer than ever before to that Venture S camper van, mirroring it outside and in.

Downsizing to a tiny house with a family is always going to be a challenge, but the Kookaburra 2.0 has been designed to smooth the process along. It features two bedrooms, a bathroom with a bathtub, and plenty of storage.

Washing a car is an extra chore, and if you live in a condo, you might not even be allowed to do it. Currently on Kickstarter, the Diisea C7 promises quick car washes without getting you into an argument with the condo board.

Human blood proteins have been found binding pigments in ancient rock art paintings in Southern China, potentially helping them survive the elements for more than 2,000 years.

Longevity has become a bit of a buzz word, and has become increasingly aligned with the tech industry. But a timely report from Harvard Medical School reminds us that we have a lot of power when it comes to how we age – and it's backed by science.

In somewhat of a surprise announcement, the Food and Drug Administration has approved the first US influenza vaccine engineered from the mRNA technology that gave us one of the most administered COVID-19 shots during the pandemic.

“Remove the plank from your eye before pointing out the speck in another’s,” says a popular proverb. For millions with geographic atrophy, the speck is literal. Relief may now be coming, after a sight-restoring implant received approval for sale in Europe.

An AI present in your consultation promises better notes, less admin and more time for patients, but what exactly is being recorded, where does the data go, and did anyone really ask for your consent?

Hookworms are freeloaders that live at the host’s expense inside their gut, drinking about two drops of blood per day. This parasite could soon pay its way with engineered hookworms serving as living medicine factories.

Some people can’t get their bad cholesterol levels down, even if they take cholesterol-lowering meds. A clinical trial using a combination of existing and not-yet-released cholesterol tablets lowered bad cholesterol by almost half.

Shoei has just launched the GT-Air 3 Smart, the world’s first moto helmet to feature fully integrated augmented reality thanks to a partnership with EyeLights, which specializes in head-up displays and Bluetooth audio kits.

Yamaha has been working with storied British carmaker Caterham on its new electric sports car. Dubbed the Project V, it is finally here. And not only is it coming to America, but it is coming for Porsche.

The Mysa 400 by Irontown Modular is an extra-wide tiny house that features an apartment-style interior with a spacious living area, two bedrooms, and an open design that's suited to full-time living.

Bürstner has teased some impressive new vehicle debuts ahead of the world's largest RV show. Among them, the Signature series subtly deletes the division between camper van and motorhome with a sleek, semi-integrated body and transformable interior.

Despite its critics and moves toward electrification, the internal combustion engine is not yet dead. Though its design for passenger vehicles may have begun to reach its apex with Mazda’s Skyactiv designs.

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug that offers 100% protection with its twice-yearly injections. It's a landmark achievement set to save millions of lives.

All I wanted to do was get rid of my glasses, but when my local laser eye surgery clinic recommended some odd-sounding, advanced Presbyond treatment developed by Zeiss, I said sure, if that's what the cool kids are getting. Here's what's happened.